Drug intelligence / Profile preview

CareImmun

Development stage: Unknown
Lead developer: biosyn Arzneimittel
Modality: Small Molecules
Administration: Oral

Overview

CareImmun is a multi-ingredient dietary supplement developed by biosyn Arzneimittel GmbH to support immune system health and address micronutrient deficiencies. It is available in formulations such as CAREIMMUN Basic and CAREIMMUN Onco, the latter specifically designed for patients with high risks of malnutrition, such as those undergoing cancer treatment, living with HIV, or in palliative care. The product contains a combination of vitamins (B2, B6, B12, C, D3, and methyltetrahydrofolate), minerals (selenium, zinc, copper), coenzyme Q10, and carotenoids (lycopene and lutein). It utilizes a unique pellet-in-capsule delivery system to prevent interactions between the various micronutrients and ensure optimal absorption.

Brand names: CareImmunCAREIMMUN BasicCAREIMMUN Onco

Beyond the preview

Go deeper on CareImmun.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CareImmun.

Explore the full profile